Al-Dughaishi, M., Shalaby, A., Al-Ribkhi, K., Boudaka, A., Boulassel, M.-R. and Saleh, J. 2019. The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy. Sultan Qaboos University Medical Journal. 19, 4 (Dec. 2019), e277–283. DOI:https://doi.org/10.18295/squmj.2019.19.04.002.